Excelsior Biopharma

Excelsior Biopharma FCF per Share

The Free Cash Flow per Share of Excelsior Biopharma (6496.TWO) as of Oct 28, 2026 is -3.86 TWD. In the previous year, Free Cash Flow per Share was -7.84 TWD — a change of -50.79% (higher).

FCF per Share

-3.86TWD

YoY

-50.79%

Last updated:

Free Cash Flow per Share of Excelsior Biopharma is 2025 -3.86 TWD. Free Cash Flow per Share of Excelsior Biopharma was 2024 -7.84 TWD. It decreases by -50.79% higher compared to the previous year.

The Excelsior Biopharma FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
2.58 TWD
Jan 1, 2019
-4.17 TWD
Jan 1, 2020
10.91 TWD
Jan 1, 2021
1.13 TWD
Jan 1, 2022
-0.05 TWD
Jan 1, 2023
-3.64 TWD
Jan 1, 2024
-7.84 TWD
Jan 1, 2025
-3.86 TWD
The Excelsior Biopharma FCF per Share history
YEARFCF per ShareYoY
-3.86TWD-50.79%
-7.84TWD+115.43%
-3.64TWD+7,294.78%
-0.05TWD-104.34%
1.13TWD-89.60%
10.91TWD-361.40%
-4.17TWD-261.97%
2.58TWD-64.58%
7.28TWD+91.42%
3.80TWD+6,584.18%
0.06TWD-97.78%
2.56TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Excelsior Biopharma Stock analysis

What does Excelsior Biopharma do? Excelsior Biopharma Inc., headquartered in Taipei City, Taiwan, operates in the Health Care sector. The company focuses on the research, development, manufacturing, and distribution of pharmaceutical products, including prescription and non-prescription drugs, health care products, medical equipment, and rapid test reagents. Listed on 19 December 2014, Excelsior Biopharma serves both domestic and international markets with its diverse product portfolio. Excelsior Biopharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Excelsior Biopharma stock

Free Cash Flow per Share of Excelsior Biopharma is -3.86 TWD in 2025.

Free Cash Flow per Share of Excelsior Biopharma changed from -7.84 TWD to -3.86 TWD, representing a -50.79% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Excelsior Biopharma since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Excelsior Biopharma

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Excelsior Biopharma